Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| UNITED THERAPEUTICS CorpUTHR · Entity 664 | PRESIDENT AND COO | May 13, 2026 | May 14, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
UNITED THERAPEUTICS Corp
Report date May 13, 2026 · Filed May 14, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $217.50 · Expires 2033-03-15 | Direct | 0 |
Reported balance
After 2026-05-13 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-05-13 · Gift · Disposed 11,728 · Balance 0 F1: On March 13, 2026, the Reporting Person transferred stock options to a trust beneficially owned by the Reporting Person, of which the Reporting Person's family members are beneficiaries, and as to which the Reporting Person has sole investment and voting power. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $217.50 · Expires 2033-03-15 | Indirectby Trust | 99,720 |
Reported balance
After 2026-05-13 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-05-13 · Gift · Acquired 11,728 · Balance 99,720 F1: On March 13, 2026, the Reporting Person transferred stock options to a trust beneficially owned by the Reporting Person, of which the Reporting Person's family members are beneficiaries, and as to which the Reporting Person has sole investment and voting power. F2: Held in trusts beneficially owned by the Reporting Person, of which the Reporting Person or his family members are beneficiaries, and as to which the Reporting Person has sole investment and voting power. |
Filing footnotes · ownership attribution and instrument terms
F1: On March 13, 2026, the Reporting Person transferred stock options to a trust beneficially owned by the Reporting Person, of which the Reporting Person's family members are beneficiaries, and as to which the Reporting Person has sole investment and voting power.
F2: Held in trusts beneficially owned by the Reporting Person, of which the Reporting Person or his family members are beneficiaries, and as to which the Reporting Person has sole investment and voting power.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 15, 2023 Filed Feb 26, 2026 21:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | GrantRestricted Stock Units · Derivative | 15,592 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001673232-26-000012 · primarydocument.xml · derivative · entry 2 BENKOWITZ MICHAEL · CIK 0001673232 · PRESIDENT AND COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,592 Underlying: Common Stock · 15,592 shares Expires not disclosed F2 · security: These performance-based restricted stock units were initially awarded on March 15, 2023, subject to a three-year performance condition tied to average revenue growth during 2023-2025, which was determined on February 25, 2026. The number of restricted stock units reported represents the number of restricted stock units earned based on performance, all of which will vest on March 15, 2026. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock. F4 · derivative.expiration_date: Not applicable as restricted stock units do not have an expiration date. Read SEC document |
| March 15, 2023 Filed Feb 26, 2026 21:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | GrantStock Options · Derivative | 99,720 | $0.00 Strike: $217.50 | $0.00 |
DisclosureSEC source: 0001673232-26-000012 · primarydocument.xml · derivative · entry 1 BENKOWITZ MICHAEL · CIK 0001673232 · PRESIDENT AND COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,720 Underlying: Common Stock · 99,720 shares Expires 2033-03-15 F1 · security: These performance-based stock options were initially awarded on March 15, 2023, subject to a three-year performance condition tied to average cash profit margin during 2023-2025, which was determined on February 25, 2026. The number of stock options reported represents the number of options earned based on performance, all of which will vest on March 15, 2026. Read SEC document |
| December 29, 2022 Filed Jan 3, 2023 21:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionShare Tracking Award · Derivative | 5,000 | $0.00 Strike: $163.30 | $0.00 |
DisclosureSEC source: 0001415889-23-000056 · form4-01032023_040102.xml · derivative · entry 3 BENKOWITZ MICHAEL · CIK 0001673232 · PRESIDENT AND COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,200 Underlying: Common Stock · 5,000 shares Expires 2025-03-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. F1 · kind: This is an exercise of share tracking awards pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| December 29, 2022 Filed Jan 3, 2023 21:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 5,000 | $275.99 | $1,379,950.00 |
DisclosureSEC source: 0001415889-23-000056 · form4-01032023_040102.xml · nonDerivative · entry 2 BENKOWITZ MICHAEL · CIK 0001673232 · PRESIDENT AND COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,353 F1 · kind: This is an exercise of share tracking awards pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| December 29, 2022 Filed Jan 3, 2023 21:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 5,000 | $163.30 | $816,500.00 |
DisclosureSEC source: 0001415889-23-000056 · form4-01032023_040102.xml · nonDerivative · entry 1 BENKOWITZ MICHAEL · CIK 0001673232 · PRESIDENT AND COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,353 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This is an exercise of share tracking awards pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| December 22, 2022 Filed Dec 23, 2022 21:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionShare Tracking Award · Derivative | 8,000 | $0.00 Strike: $94.96 | $0.00 |
DisclosureSEC source: 0001415889-22-012967 · form4-12232022_041201.xml · derivative · entry 3 BENKOWITZ MICHAEL · CIK 0001673232 · PRESIDENT AND COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,000 shares Expires 2024-03-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. F1 · kind: This is an exercise of share tracking awards pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| December 22, 2022 Filed Dec 23, 2022 21:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Disposition to issuerCommon Stock | 8,000 | $277.25 | $2,218,000.00 |
DisclosureSEC source: 0001415889-22-012967 · form4-12232022_041201.xml · nonDerivative · entry 2 BENKOWITZ MICHAEL · CIK 0001673232 · PRESIDENT AND COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,353 F1 · kind: This is an exercise of share tracking awards pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| December 22, 2022 Filed Dec 23, 2022 21:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 8,000 | $94.96 | $759,680.00 |
DisclosureSEC source: 0001415889-22-012967 · form4-12232022_041201.xml · nonDerivative · entry 1 BENKOWITZ MICHAEL · CIK 0001673232 · PRESIDENT AND COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,353 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This is an exercise of share tracking awards pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| December 20, 2022 Filed Dec 21, 2022 21:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionShare Tracking Award · Derivative | 8,000 | $0.00 Strike: $94.96 | $0.00 |
DisclosureSEC source: 0001415889-22-012885 · form4-12212022_041202.xml · derivative · entry 3 BENKOWITZ MICHAEL · CIK 0001673232 · PRESIDENT AND COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Underlying: Common Stock · 8,000 shares Expires 2024-03-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Share tracking awards are non-dilutive, cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. F1 · kind: This is an exercise of share tracking awards. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| December 20, 2022 Filed Dec 21, 2022 21:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Disposition to issuerCommon Stock | 8,000 | $274.05 | $2,192,400.00 |
DisclosureSEC source: 0001415889-22-012885 · form4-12212022_041202.xml · nonDerivative · entry 2 BENKOWITZ MICHAEL · CIK 0001673232 · PRESIDENT AND COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,353 F1 · kind: This is an exercise of share tracking awards. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| December 20, 2022 Filed Dec 21, 2022 21:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 8,000 | $94.96 | $759,680.00 |
DisclosureSEC source: 0001415889-22-012885 · form4-12212022_041202.xml · nonDerivative · entry 1 BENKOWITZ MICHAEL · CIK 0001673232 · PRESIDENT AND COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,353 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This is an exercise of share tracking awards. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| December 15, 2022 Filed Dec 16, 2022 21:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionShare Tracking Award · Derivative | 8,000 | $0.00 Strike: $94.96 | $0.00 |
DisclosureSEC source: 0001415889-22-012637 · form4-12162022_041214.xml · derivative · entry 3 BENKOWITZ MICHAEL · CIK 0001673232 · PRESIDENT AND COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,000 Underlying: Common Stock · 8,000 shares Expires 2024-03-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. F1 · kind: This is an exercise of share tracking awards. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| December 15, 2022 Filed Dec 16, 2022 21:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Disposition to issuerCommon Stock | 8,000 | $275.85 | $2,206,800.00 |
DisclosureSEC source: 0001415889-22-012637 · form4-12162022_041214.xml · nonDerivative · entry 2 BENKOWITZ MICHAEL · CIK 0001673232 · PRESIDENT AND COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,353 F1 · kind: This is an exercise of share tracking awards. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| December 15, 2022 Filed Dec 16, 2022 21:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 8,000 | $94.96 | $759,680.00 |
DisclosureSEC source: 0001415889-22-012637 · form4-12162022_041214.xml · nonDerivative · entry 1 BENKOWITZ MICHAEL · CIK 0001673232 · PRESIDENT AND COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,353 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This is an exercise of share tracking awards. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| December 13, 2022 Filed Dec 14, 2022 21:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionShare Tracking Award · Derivative | 8,000 | $0.00 Strike: $94.96 | $0.00 |
DisclosureSEC source: 0001415889-22-012538 · form4-12142022_041201.xml · derivative · entry 3 BENKOWITZ MICHAEL · CIK 0001673232 · PRESIDENT AND COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,000 Underlying: Common Stock · 8,000 shares Expires 2024-03-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| December 13, 2022 Filed Dec 14, 2022 21:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Disposition to issuerCommon Stock | 8,000 | $276.43 | $2,211,440.00 |
DisclosureSEC source: 0001415889-22-012538 · form4-12142022_041201.xml · nonDerivative · entry 2 BENKOWITZ MICHAEL · CIK 0001673232 · PRESIDENT AND COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,353 F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| December 13, 2022 Filed Dec 14, 2022 21:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 8,000 | $94.96 | $759,680.00 |
DisclosureSEC source: 0001415889-22-012538 · form4-12142022_041201.xml · nonDerivative · entry 1 BENKOWITZ MICHAEL · CIK 0001673232 · PRESIDENT AND COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,353 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| December 08, 2022 Filed Dec 9, 2022 21:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionShare Tracking Award · Derivative | 8,000 | $0.00 Strike: $94.96 | $0.00 |
DisclosureSEC source: 0001415889-22-012320 · form4-12092022_041206.xml · derivative · entry 3 BENKOWITZ MICHAEL · CIK 0001673232 · PRESIDENT AND COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,000 Underlying: Common Stock · 8,000 shares Expires 2024-03-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| December 08, 2022 Filed Dec 9, 2022 21:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Disposition to issuerCommon Stock | 8,000 | $279.88 | $2,239,040.00 |
DisclosureSEC source: 0001415889-22-012320 · form4-12092022_041206.xml · nonDerivative · entry 2 BENKOWITZ MICHAEL · CIK 0001673232 · PRESIDENT AND COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,353 F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| December 08, 2022 Filed Dec 9, 2022 21:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 8,000 | $94.96 | $759,680.00 |
DisclosureSEC source: 0001415889-22-012320 · form4-12092022_041206.xml · nonDerivative · entry 1 BENKOWITZ MICHAEL · CIK 0001673232 · PRESIDENT AND COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,353 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| December 21, 2021 Filed Dec 22, 2021 21:32 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionShare Tracking Award · Derivative | 2,400 | $0.00 Strike: $61.06 | $0.00 |
DisclosureSEC source: 0001127602-21-031786 · form4.xml · derivative · entry 3 BENKOWITZ MICHAEL · CIK 0001673232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,400 shares Expires 2023-03-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| December 21, 2021 Filed Dec 22, 2021 21:32 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Disposition to issuerCommon Stock | 2,400 | $205.12 | $492,288.00 |
DisclosureSEC source: 0001127602-21-031786 · form4.xml · nonDerivative · entry 2 BENKOWITZ MICHAEL · CIK 0001673232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,235 F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| December 21, 2021 Filed Dec 22, 2021 21:32 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 2,400 | $61.06 | $146,544.00 |
DisclosureSEC source: 0001127602-21-031786 · form4.xml · nonDerivative · entry 1 BENKOWITZ MICHAEL · CIK 0001673232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,635 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| December 16, 2021 Filed Dec 17, 2021 21:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionShare Tracking Award · Derivative | 4,000 | $0.00 Strike: $61.06 | $0.00 |
DisclosureSEC source: 0001127602-21-031379 · form4.xml · derivative · entry 3 BENKOWITZ MICHAEL · CIK 0001673232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,400 Underlying: Common Stock · 4,000 shares Expires 2023-03-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| December 16, 2021 Filed Dec 17, 2021 21:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Disposition to issuerCommon Stock | 4,000 | $195.86 | $783,440.00 |
DisclosureSEC source: 0001127602-21-031379 · form4.xml · nonDerivative · entry 2 BENKOWITZ MICHAEL · CIK 0001673232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,235 F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| December 16, 2021 Filed Dec 17, 2021 21:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 4,000 | $61.06 | $244,240.00 |
DisclosureSEC source: 0001127602-21-031379 · form4.xml · nonDerivative · entry 1 BENKOWITZ MICHAEL · CIK 0001673232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,235 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| December 14, 2021 Filed Dec 15, 2021 21:32 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionShare Tracking Award · Derivative | 4,000 | $0.00 Strike: $61.06 | $0.00 |
DisclosureSEC source: 0001127602-21-030992 · form4.xml · derivative · entry 3 BENKOWITZ MICHAEL · CIK 0001673232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,400 Underlying: Common Stock · 4,000 shares Expires 2023-03-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| December 14, 2021 Filed Dec 15, 2021 21:32 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Disposition to issuerCommon Stock | 4,000 | $193.93 | $775,720.00 |
DisclosureSEC source: 0001127602-21-030992 · form4.xml · nonDerivative · entry 2 BENKOWITZ MICHAEL · CIK 0001673232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,235 F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| December 14, 2021 Filed Dec 15, 2021 21:32 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 4,000 | $61.06 | $244,240.00 |
DisclosureSEC source: 0001127602-21-030992 · form4.xml · nonDerivative · entry 1 BENKOWITZ MICHAEL · CIK 0001673232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,235 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| December 07, 2021 Filed Dec 8, 2021 22:02 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionShare Tracking Award · Derivative | 4,000 | $0.00 Strike: $61.06 | $0.00 |
DisclosureSEC source: 0001127602-21-030550 · form4.xml · derivative · entry 3 BENKOWITZ MICHAEL · CIK 0001673232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,400 Underlying: Common Stock · 4,000 shares Expires 2023-03-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| December 07, 2021 Filed Dec 8, 2021 22:02 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Disposition to issuerCommon Stock | 4,000 | $190.41 | $761,640.00 |
DisclosureSEC source: 0001127602-21-030550 · form4.xml · nonDerivative · entry 2 BENKOWITZ MICHAEL · CIK 0001673232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,235 F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| December 07, 2021 Filed Dec 8, 2021 22:02 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 4,000 | $61.06 | $244,240.00 |
DisclosureSEC source: 0001127602-21-030550 · form4.xml · nonDerivative · entry 1 BENKOWITZ MICHAEL · CIK 0001673232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,235 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| November 23, 2021 Filed Nov 24, 2021 21:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionShare Tracking Award · Derivative | 4,000 | $0.00 Strike: $61.06 | $0.00 |
DisclosureSEC source: 0001104659-21-143597 · tm2133880-1_4seq1.xml · derivative · entry 3 BENKOWITZ MICHAEL · CIK 0001673232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,400 Underlying: Common Stock · 4,000 shares Expires 2023-03-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| November 23, 2021 Filed Nov 24, 2021 21:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Disposition to issuerCommon Stock | 4,000 | $201.58 | $806,320.00 |
DisclosureSEC source: 0001104659-21-143597 · tm2133880-1_4seq1.xml · nonDerivative · entry 2 BENKOWITZ MICHAEL · CIK 0001673232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,235 F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| November 23, 2021 Filed Nov 24, 2021 21:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 4,000 | $61.06 | $244,240.00 |
DisclosureSEC source: 0001104659-21-143597 · tm2133880-1_4seq1.xml · nonDerivative · entry 1 BENKOWITZ MICHAEL · CIK 0001673232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,235 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| November 18, 2021 Filed Nov 19, 2021 21:57 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionShare Tracking Award · Derivative | 4,000 | $0.00 Strike: $53.83 | $0.00 |
DisclosureSEC source: 0001127602-21-029725 · form4.xml · derivative · entry 3 BENKOWITZ MICHAEL · CIK 0001673232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,000 shares Expires 2023-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| November 18, 2021 Filed Nov 19, 2021 21:57 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Disposition to issuerCommon Stock | 4,000 | $202.61 | $810,440.00 |
DisclosureSEC source: 0001127602-21-029725 · form4.xml · nonDerivative · entry 2 BENKOWITZ MICHAEL · CIK 0001673232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,235 F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| November 18, 2021 Filed Nov 19, 2021 21:57 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 4,000 | $53.83 | $215,320.00 |
DisclosureSEC source: 0001127602-21-029725 · form4.xml · nonDerivative · entry 1 BENKOWITZ MICHAEL · CIK 0001673232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,235 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| November 16, 2021 Filed Nov 17, 2021 22:40 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionShare Tracking Award · Derivative | 4,000 | $0.00 Strike: $53.83 | $0.00 |
DisclosureSEC source: 0001127602-21-029479 · form4.xml · derivative · entry 3 BENKOWITZ MICHAEL · CIK 0001673232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 Underlying: Common Stock · 4,000 shares Expires 2023-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| November 16, 2021 Filed Nov 17, 2021 22:40 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Disposition to issuerCommon Stock | 4,000 | $203.24 | $812,960.00 |
DisclosureSEC source: 0001127602-21-029479 · form4.xml · nonDerivative · entry 2 BENKOWITZ MICHAEL · CIK 0001673232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,235 F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| November 16, 2021 Filed Nov 17, 2021 22:40 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 4,000 | $53.83 | $215,320.00 |
DisclosureSEC source: 0001127602-21-029479 · form4.xml · nonDerivative · entry 1 BENKOWITZ MICHAEL · CIK 0001673232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,235 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| November 11, 2021 Filed Nov 12, 2021 21:33 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionShare Tracking Award · Derivative | 4,000 | $0.00 Strike: $53.83 | $0.00 |
DisclosureSEC source: 0001127602-21-028986 · form4.xml · derivative · entry 3 BENKOWITZ MICHAEL · CIK 0001673232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Underlying: Common Stock · 4,000 shares Expires 2023-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| November 11, 2021 Filed Nov 12, 2021 21:33 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Disposition to issuerCommon Stock | 4,000 | $200.90 | $803,600.00 |
DisclosureSEC source: 0001127602-21-028986 · form4.xml · nonDerivative · entry 2 BENKOWITZ MICHAEL · CIK 0001673232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,235 F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| November 11, 2021 Filed Nov 12, 2021 21:33 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 4,000 | $53.83 | $215,320.00 |
DisclosureSEC source: 0001127602-21-028986 · form4.xml · nonDerivative · entry 1 BENKOWITZ MICHAEL · CIK 0001673232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,235 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| November 09, 2021 Filed Nov 10, 2021 21:34 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionShare Tracking Award · Derivative | 4,000 | $0.00 Strike: $53.83 | $0.00 |
DisclosureSEC source: 0001127602-21-028821 · form4.xml · derivative · entry 3 BENKOWITZ MICHAEL · CIK 0001673232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 4,000 shares Expires 2023-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| November 09, 2021 Filed Nov 10, 2021 21:34 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Disposition to issuerCommon Stock | 4,000 | $198.93 | $795,720.00 |
DisclosureSEC source: 0001127602-21-028821 · form4.xml · nonDerivative · entry 2 BENKOWITZ MICHAEL · CIK 0001673232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,235 F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| November 09, 2021 Filed Nov 10, 2021 21:34 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 4,000 | $53.83 | $215,320.00 |
DisclosureSEC source: 0001127602-21-028821 · form4.xml · nonDerivative · entry 1 BENKOWITZ MICHAEL · CIK 0001673232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,235 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| November 04, 2021 Filed Nov 5, 2021 20:31 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionShare Tracking Award · Derivative | 4,000 | $0.00 Strike: $53.83 | $0.00 |
DisclosureSEC source: 0001127602-21-028477 · form4.xml · derivative · entry 3 BENKOWITZ MICHAEL · CIK 0001673232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,000 Underlying: Common Stock · 4,000 shares Expires 2023-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| November 04, 2021 Filed Nov 5, 2021 20:31 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Disposition to issuerCommon Stock | 4,000 | $201.44 | $805,760.00 |
DisclosureSEC source: 0001127602-21-028477 · form4.xml · nonDerivative · entry 2 BENKOWITZ MICHAEL · CIK 0001673232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,235 F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
| November 04, 2021 Filed Nov 5, 2021 20:31 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 4,000 | $53.83 | $215,320.00 |
DisclosureSEC source: 0001127602-21-028477 · form4.xml · nonDerivative · entry 1 BENKOWITZ MICHAEL · CIK 0001673232 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,235 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.